Lantern Pharma Inc. (LTRN)
Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-300 as a combination therapy for non or never-smokers with non-small cell lung cancer adenocarcinoma. In addition, its preclinical development drug candidate is LP-184, an alkylating agent that damages DNA in cancer cells that overexpress certain biomarkers or that harbor mutations in DNA repair pathways. Further, the company operates ADC program, an antibody drug conjugate therapeutic approach for cancer treatment. Additionally, the company's artificial intelligence platform RADR uses big data analytics and machine learning for combining molecular data. The company was incorporated in 2013 and is headquartered in Dallas, Texas.
$43.81M
Mr. Panna Sharma PH.D.
14.00
Dallas, TX
Jun 11, 2020
-2.47
$-1.65
2.82
7.67
-6,798.53%
-2.31
0.02
1.33
157.11
7.67
-49.87%
-46.39%
Similar stocks (5)
Immunome, Inc.
IMNM
Generation Bio Co.
GBIO
Cue Biopharma, Inc.
CUE
Lyra Therapeutics, Inc.
LYRA
TFF Pharmaceuticals, Inc.
TFFP
ETF Exposure (12)
Listed Funds Trust - Horizon Kinetics Medical ETF
MEDX
0.5499999999999999%
iShares Micro-Cap ETF
IWC
0.00681%
Dimensional US Sustainability Core 1 ETF
DFSU
6.0834e-4%
Dimensional U.S. Targeted Value ETF
DFAT
1.0279999999999999e-4%
Dimensional U.S. Core Equity 2 ETF
DFAC
5.8960000000000005e-5%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (5)
Immunome, Inc.
IMNM
Generation Bio Co.
GBIO
Cue Biopharma, Inc.
CUE
Lyra Therapeutics, Inc.
LYRA
TFF Pharmaceuticals, Inc.
TFFP
ETF Exposure (12)
Listed Funds Trust - Horizon Kinetics Medical ETF
MEDX
0.5499999999999999%
iShares Micro-Cap ETF
IWC
0.00681%
Dimensional US Sustainability Core 1 ETF
DFSU
6.0834e-4%
Dimensional U.S. Targeted Value ETF
DFAT
1.0279999999999999e-4%
Dimensional U.S. Core Equity 2 ETF
DFAC
5.8960000000000005e-5%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%